How Healthcare Moves from Reactive Care to Preventive with Ray Pawlicki
July 1, 2026
Healthcare systems all around the world are under pressure, and the common denominator is chronic disease. In this episode of Biology Matters, Ray Pawlicki, Executive Chairman at PrecisionLife, and host Steve Gardner explore how a shift from reacting to illness toward diagnosing, treating, and preventing disease much earlier is the solution we need to relieve this pressure. Drawing on decades of leadership experience across Novartis, Biogen, UMass Memorial Health, and beyond, Ray explains why technology is now a strategic priority in healthcare, why culture matters just as much as data, and why solving chronic disease will require new thinking on the part of providers, payers, patients, and healthcare leaders alike.
Healthcare systems around the world are facing a difficult reality: more people are living longer, but with multiple chronic diseases that are expensive, difficult to manage, and usually diagnosed too late. In this episode of Biology Matters, Ray Pawlicki, Executive Chairman at PrecisionLife, and host Steve Gardner, unpack why this isn’t just a medical challenge but a technology, leadership, and culture challenge.
What You'll Learn:
- The distinct hurdles healthcare faces compared to other industries when adopting technology.
- How culture, leadership, and communication shape successful healthcare transformation
- Why chronic disease is one of the biggest drivers of healthcare spending and system pressure
- Why earlier diagnosis and disease-modifying therapies are essential for long-term health
- Where AI can genuinely help healthcare (and where it cannot replace biological understanding)
- Why the future of healthcare depends on moving from reactive treatment to precision prevention
About Ray
Ray Pawlicki is Executive Chairman at PrecisionLife and a technology leader with decades of experience across life sciences, healthcare, consumer goods, financial services, and technology. He has held senior leadership roles at organizations including Novartis, Biogen, UMass Memorial Health, PepsiCo, Citibank, and Hewlett Packard.
Over the course of his career, he has worked closely with leadership to make technology and data central to the company’s transformation and lead major culture-change initiatives designed to support more collaborative, science-led, and data-driven ways of working. Today, Ray brings this cross-industry perspective to PrecisionLife, where he focuses on how technology, data, and precision medicine can help healthcare systems diagnose disease earlier, treat patients more effectively, and shift toward prevention.
About Steve
Steve Gardner is CEO and Co-Founder of Precision Life, recognized for his expertise in mechanism-based biology and its application to chronic disease management. With over 25 years of experience in life sciences and informatics, he has contributed to the Human Genome Project, led over 30 drug discovery and development initiatives, and built multiple healthcare and AI technologies from concept to market. His work bridging computational biology with clinical translation has positioned him at the forefront of precision medicine for complex chronic conditions - a space historically overlooked in favor of oncology-focused approaches.
Episode Resources:
Ray Pawlicki on LinkedIn
Biology Matters is handcrafted by our friends over at: fame.so